UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027156 |
|---|---|
| Receipt number | R000031121 |
| Scientific Title | Web-based survey on allergic diseases of the eye |
| Date of disclosure of the study information | 2017/04/27 |
| Last modified on | 2024/02/15 13:14:21 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Web-based survey on allergic diseases of the eye
Acronym
Web-based survey on allergic diseases of the eye
Scientific Title
Web-based survey on allergic diseases of the eye
Scientific Title:Acronym
Web-based survey on allergic diseases of the eye
Region
| Japan |
Condition
Condition
Allergic conjunctival disease
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Acquire patient background data on allergic conjunctival disease and expand it as evidence of epidemiology at the time of revision of the clinical practice guideline in the future and use it for the prevention and treatment of diseases.
Ask a questionnaire about allergic diseases for ophthalmologists and their families
Basic objectives2
Others
Basic objectives -Others
Prevalence
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Prevalence of allergic conjunctival disease
Relationship between allergic conjunctival disease and background of Patients
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Ophthalmologists and their family members who give approval and answer questionnaires in the Web site.
Key exclusion criteria
not applicable
Target sample size
1000
Research contact person
Name of lead principal investigator
| 1st name | Kazumi |
| Middle name | |
| Last name | Fukagawa |
Organization
Japanese Ocular Allergology Society
Division name
-
Zip code
169-0075
Address
2-4-7, Takadanobaba, Shinjuku-ku, Tokyo 169-0075, Japan
TEL
03-5287-3801
joas_sec@staffroom.jp
Public contact
Name of contact person
| 1st name | Kazumi |
| Middle name | |
| Last name | Fukagawa |
Organization
Japanese Ocular Allergology Society
Division name
-
Zip code
169-0075
Address
2-4-7, Takadanobaba, Shinjuku-ku, Tokyo 169-0075, Japan
TEL
03-5287-3801
Homepage URL
joas_sec@staffroom.jp
Sponsor or person
Institute
Japanese Ocular Allergology Society
Institute
Department
Personal name
Funding Source
Organization
Santen Pharmaceutical Co., Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Medical Corporation Keishokai Ryogoku Ophthalmology Clinic Ethics Review Committee
Address
4-33-12 Ryogoku, Sumida-ku, Tokyo
Tel
03-5600-6886
chisato-higashi@j-smo.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 04 | Month | 27 | Day |
Related information
URL releasing protocol
None
Publication of results
Published
Result
URL related to results and publications
https://www.ncbi.nlm.nih.gov/pubmed/?term=Air+pollution+significantly+associated+with+severe+ocular+
Number of participants that the trial has enrolled
3014
Results
We obtained responses from 3004 cases (1498 males). Among systemic allergic diseases, allergic conjunctival disease was the most common (46.4%), followed by allergic rhinitis (34.1%), atopic dermatitis (7.8%), and asthma (5.8%). The prevalence of severe forms of atopic keratoconjunctivitis and spring catarrh were 5.5% and 1.3%, respectively.
Results date posted
| 2024 | Year | 02 | Month | 15 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Refer to paper
Participant flow
Refer to paper
Adverse events
Not applicable due to web-based survey
Outcome measures
Prevalence of Allergic Conjunctivitis
Prevalence of severe allergic conjunctival lesions
Allergic Conjunctival Disease Associated with Various Study Subject Backgrounds
Plan to share IPD
The dataset is not publicly available.
IPD sharing Plan description
The dataset is not publicly available.
Progress
Recruitment status
Completed
Date of protocol fixation
| 2017 | Year | 03 | Month | 17 | Day |
Date of IRB
| 2017 | Year | 03 | Month | 27 | Day |
Anticipated trial start date
| 2017 | Year | 04 | Month | 06 | Day |
Last follow-up date
| 2017 | Year | 05 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
To understanding prevalence of allergic conjunctival disease
Management information
Registered date
| 2017 | Year | 04 | Month | 27 | Day |
Last modified on
| 2024 | Year | 02 | Month | 15 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031121
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
